Issuer positions
3
Reporting Owner Activity for Rachel K. King
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
GLYCOMIMETICS INC
Disclosed value
$2.03M
Recent activity
Available
- Location
- Gaithersburg, MD
- Ownership summary
-
Disclosed holdings value
$2,028,198
Estimated from parsed Forms 3/4/5 holdings when values are available.
Issuer positions
3
Distinct issuers linked to this reporting owner in parsed SEC filings.
Largest parsed position
CRESCENT BIOPHARMA, INC. (CBIO)
About $1.55M reported in parsed filings.
Latest ownership filing
30 Jun 2025
Most recent owner-level filing date in the parsed SEC record.
Values come from parsed SEC Forms 3/4/5 and should be verified against the source filing.
- Reporting signature
- /s/ Alan Musso, as attorney-in-fact for Rachel King
- Source filings
- Open source filing history
Identity
SEC ownership signals
SEC record
SEC evidence
Follow Filing Activity
Follow Rachel K. King and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Rachel K. King
CBIO
Forms 3/4/5
GLYCOMIMETICS INC
- Relationship
- Director
- Holdings value
- $1,545,582
- Past year net change
- Change %
- Report period
- 01 May 2024
NVAX
Forms 3/4/5
NOVAVAX INC
- Relationship
- Director
- Holdings value
- $482,616
- Past year net change
- Change %
- Report period
- 20 Jun 2025
FULC
Forms 3/4/5
Fulcrum Therapeutics, Inc.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 26 Jun 2025
Insider Transactions Reported by Rachel K. King:
| Sym | Company | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.